New positivity with the Dow breaking 30,000 for the first time, due in part to hopes for; a vaccine and a peaceful transition for the Biden administration.
Astra Zeneca announced the results of their trials, with efficacy up to 90 percent with a drug that is cheaper to produce and easier to distribute.
NAB has revised its forecasts for growth in the Australia economy.
Markets continue to be torn between the good news and the bad news.
There was no new vaccine news overnight and the markets seemed a little disappointed by that, with equities down and a move to government bonds.
NAB's relief package for business.
you improve your business.
NAB supports customers
in their story of progress.